1707 Stock Overview
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
My Notes
NewNotes are coming soon
Grape King Bio Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$174.00 |
| 52 Week High | NT$178.00 |
| 52 Week Low | NT$120.00 |
| Beta | 0.44 |
| 1 Month Change | 5.45% |
| 3 Month Change | 35.94% |
| 1 Year Change | 12.62% |
| 3 Year Change | -7.45% |
| 5 Year Change | -13.00% |
| Change since IPO | 175.10% |
Recent News & Updates
Recent updates
Grape King Bio (TPE:1707) Knows How To Allocate Capital
Apr 06
Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You Think
Mar 06How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 27Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Shareholder Returns
| 1707 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | 4.8% | 7.7% | 4.6% |
| 1Y | 12.6% | 13.5% | -11.6% |
Return vs Industry: 1707 matched the TW Personal Products industry which returned 13.5% over the past year.
Return vs Market: 1707 exceeded the TW Market which returned -11.6% over the past year.
Price Volatility
| 1707 volatility | |
|---|---|
| 1707 Average Weekly Movement | 3.9% |
| Personal Products Industry Average Movement | 5.8% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in TW Market | 7.2% |
| 10% least volatile stocks in TW Market | 1.8% |
Stable Share Price: 1707 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 1707's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1969 | n/a | n/a | https://www.grapeking.com.tw |
Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes.
Grape King Bio Ltd Fundamentals Summary
| 1707 fundamental statistics | |
|---|---|
| Market Cap | NT$25.78b |
| Earnings (TTM) | NT$1.43b |
| Revenue (TTM) | NT$10.19b |
18.1x
P/E Ratio2.5x
P/S RatioIs 1707 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1707 income statement (TTM) | |
|---|---|
| Revenue | NT$10.19b |
| Cost of Revenue | NT$1.90b |
| Gross Profit | NT$8.28b |
| Other Expenses | NT$6.86b |
| Earnings | NT$1.43b |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.62 |
| Gross Margin | 81.32% |
| Net Profit Margin | 14.00% |
| Debt/Equity Ratio | 0% |
How did 1707 perform over the long term?
See historical performance and comparison